Xconomy’s Digital Events →
Derrick Gingery is a senior writer for the Pink Sheet.
Pfizer Inc. CEO Albert Bourla said he doesn’t worry about political pressure to bring potentially the first coronavirus vaccine to market, but can’t escape feeling the weight of the world on... Read more »
Expedited programs usually shorten a US Food and Drug Administration new drug application assessment, but on average, maybe not as much as their reputation would suggest.
A Government Accountability Office (GAO) ... Read more »
Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.